Cited by 67Pancreatic function and diabetesTissue Engineering and Regenerative MedicinePluripotent Stem Cells Research

The challenge of developing human 3D organoids into medicines

Open access
Vives, Joaquim, Batlle-Morera, Laura·2020·Stem Cell Research & Therapy

Abstract

The capacity of organoids to generate complex 3D structures resembling organs is revolutionizing the fields of developmental and stem cell biology. We are currently establishing the foundations for translational applications of organoids such as drug screening, personalized medicine and launching the future of cell therapy using organoids. However, clinical translation of organoids into cell replacement therapies is halted due to (A) a few preclinical studies demonstrating their efficacy and (B) the lack of robust, reproducible, and scalable methods of production in compliance with current pharmaceutical standards. In this issue of Stem Cell Research & Therapy [ref], Dossena and collaborators present a validated bioprocess design for large-scale production of human pancreatic organoids from cadaveric tissue in accordance with current good manufacturing practice. The authors also propose a set of specifications of starting materials and critical quality attributes of final products that are of interest to other developments provided that this type of medicines are different than any other medicinal product due to their complex composition and living nature of the active ingredient. Although large-scale production of functional cells secreting insulin is still a challenge, the development of methods such as the one presented by Dossena and collaborators contributes to move toward clinical use of organoids in the treatment of type 1 diabetes and opens avenues for future clinical use of organoids in degenerative pathologies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-020-1586-1

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intestinal organoids can fuse into tubular structures resembling in vivo intestines.

    “Sachs and colleagues showed that intestinal organoids could fuse into tubular structures resembling in vivo intestines148,149.”

    From Organoids (2022) · cites this paper as [149]

    The Background says organoids can resemble native organs, but it does not describe intestinal organoids fusing into tubular structures or attribute such a finding to Sachs. Searches for intestinal tubular fusion and Sachs found no passage addressing that specific claim. (LLM, conf=0.74)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [6]Vives J, Carmona G, Vives J, Carmona G. Guide to Cell Therapy GxP. 1st ed. London: Academic Press (Elsevier); 2015. p. 266.

Cited by

Sorted by citations

Authors
Vives, J., & Batlle-Morera, L.
Affiliations
Universitat Autònoma de Barcelona (ES)
Corresponding author
Vives, Joaquim
Venue
Stem Cell Research & Therapy
Published
2020-03-04
Volume
11
Issue
1
Pages
72-72
ISSN
1757-6512 (ISSN-L)
OpenAlex
W3012339302
Cited by
65
References
16
Citations by year
2026: 4 · 2025: 7 · 2024: 12 · 2023: 11 · 2022: 16 · 2021: 9 · 2020: 6
FWCI
9.60
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
Funders
  • Ministerio de Ciencia, Innovación y Universidades (PI19/01788)
  • Instituto de Salud Carlos III (RD16/0011/0028)
  • Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (2017-SGR-719)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
current good manufacturing practice, type 1 diabetes, cell replacement therapy, insulin-secreting cells, cadaveric tissue, critical quality attributes, drug screening, personalized medicine, cell therapy
MeSH terms
Humans, Organoids, Imaging, Three-Dimensional, Tissue Engineering, Regenerative Medicine, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review